Resumen
Electrophysiological studies of excitable organs usually focus on action potential (AP)-generating cells, whereas nonexcitable cells are generally considered as barriers to electrical conduction. Whether nonexcitable cells may modulate excitable cell function or even contribute to AP conduction via direct electrotonic coupling to AP-generating cells is unresolved in the heart: such coupling is present in vitro, but conclusive evidence in situ is lacking. We used genetically encoded voltage-sensitive fluorescent protein 2.3 (VSFP2.3) to monitor transmembrane potential in either myocytes or nonmyocytes of murine hearts. We confirm that VSFP2.3 allows measurement of cell type-specific electrical activity. We show that VSFP2.3, expressed solely in nonmyocytes, can report cardiomyocyte AP-like signals at the border of healed cryoinjuries. Using EM-based tomographic reconstruction, we further discovered tunneling nanotube connections between myocytes and nonmyocytes in cardiac scar border tissue. Our results provide direct electrophysiological evidence of heterocellular electrotonic coupling in native myocardium and identify tunneling nanotubes as a possible substrate for electrical cell coupling that may be in addition to previously discovered connexins at sites of myocyte-nonmyocyte contact in the heart. These findings call for reevaluation of cardiac nonmyocyte roles in electrical connectivity of the heterocellular heart.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 14852-14857 |
Número de páginas | 6 |
Publicación | Proceedings of the National Academy of Sciences of the United States of America |
Volumen | 113 |
N.º | 51 |
DOI | |
Estado | Published - dic. 20 2016 |
Nota bibliográfica
Funding Information:We thank Jakki A. Kelly-Barrett for assistance in performing cryoinjury surgeries, Andreas Hoenger and the Boulder Laboratory for 3D Electron Microscopy of Cells (funded by NIH Grant P41-GM103431) for support with 3D ET, Michael D. Schneider for providing αMHC promotor Cre mice, Leslie M. Loew for access to di-4-ANBDQPQ, the Boehringer Ingelheim Fonds for early support of the ideas underlying this study (postdoctoral fellowship to P.K.), and the Fox Chase Cancer Center for providing WT1 promotor Cre mice. T.A.Q. is funded by Canadian Institutes of Health Research Grant MOP-142424, Natural Sciences and Engineering Research Council Grant RGPIN-2016-04879, and Nova Scotia Health Research Foundation Grant MED-EST-2014-9582. T.A.Q. is a National New Investigator of the Heart and Stroke Foundation, E.A.R-Z. is an Immediate Postdoctoral Fellow, and P.K. a Senior Fellow, of the British Heart Foundation. Generation of VSFP2.3 mice was supported by an RIKEN Intramural Grant (to T.K.). This work was supported by European Research Council Advanced Grant CardioNECT (to P.K.) and the Magdi Yacoub Institute.
Publisher Copyright:
© 2016, National Academy of Sciences. All rights reserved.
ASJC Scopus Subject Areas
- General